☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Henry Ford Health System Signs Development and Commercialization Agreement with G3 Pharma for its Galectin-3 inhibitors
October 31, 2018
Sandoz's Hymiroz (adalimumab-adaz) Receives the US FDA Approval for Treatment of Chronic Autoimmune Diseases
October 31, 2018
Mirati Therapeutics Announces IND Submission of MRTX849 to Treat NSCLC & CRC
October 31, 2018
Roche Licenses Halozyme's ENHANZE Technology for ~$190M for the Development of Therapeutic Targets
October 31, 2018
Janssen's (J&J) Invokana (canagliflozin) Receives FDA Approval for MACE events in Adults with T2D
October 31, 2018
Biocardia- CellProThera & SlngXpand Collaborates to Develop and Commercialize CD34+ Stem Cells in Singapore for Myocardial Inf...
October 31, 2018
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions